Alector has stopped another Alzheimer's drug clinical trial. This is the third failure in 18 months. Here's how the biotech ...
A prolific investor in Florida banks put up $40 million in the recapitalization and will take a seat on BayFirst's board of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results